Comparative Results of Conservatively and Surgically Treated Adolescents With Triplane and Juvenile Tillaux Ankle Fractures After Skeletal Maturity

This study has been terminated.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00541580
First received: October 7, 2007
Last updated: September 15, 2011
Last verified: September 2011
  Purpose

Triplane and Juvenile Tillaux fractures of the ankle are well known in adolescent pediatric population. It is widely accepted, that optimal treatment for displaced fractures is close or open reduction and fixation with screws under general anesthesia and under intraoperative fluoroscopy control. Usually a small degree of displacement (up to 2mm) is expected to be healed without any sequences. Until now, no evidence of ankle function and pain after skeletal maturity or long follow-up was published. More than that, no comparative study between operative and no operative treatment of mild and borderline displaced fractures were published.

The purpose of this study is to evaluate functional and radiographic results of operatively and conservatively treated patients after they reach skeletal maturity.


Condition
Ankle Injuries

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

  Eligibility

Ages Eligible for Study:   18 Years to 25 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

adolescents with triplane and juvenile Tillaux ankle fractures

Criteria

Inclusion Criteria:

  • Sign informed consent.

Exclusion Criteria:

  • Pregnancy
  • Unwillingness to sign the informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541580

Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Vladimir Goldman, MD Hadassah Medical Organization
Study Director: Neum Simanovsky, MD Hadassah Medical Organization
Study Chair: Natalia Simanovski, MD Hadassah Medical Organization
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00541580     History of Changes
Other Study ID Numbers: GOLD-001-HMO-CTIL
Study First Received: October 7, 2007
Last Updated: September 15, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Ankle Injuries
Wounds and Injuries
Leg Injuries

ClinicalTrials.gov processed this record on August 21, 2014